Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback